Dr. B. Lal Clinical Laboratory Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 25-06-2024
- Paid Up Capital ₹ 1.02 Cr
as on 25-06-2024
- Company Age 30 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.30 M
as on 25-06-2024
- Revenue -18.24%
(FY 2022)
- Profit -41.07%
(FY 2022)
- Ebitda -42.87%
(FY 2022)
- Net Worth 29.02%
(FY 2022)
- Total Assets 19.14%
(FY 2022)
About Dr. B. Lal Clinical Laboratory
The Corporate was formerly known as Dr B Lals Institute Of Immunology And Biotechnology Research Centre Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.02 Cr.
The company has closed loans amounting to ₹2.30 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Banwari Gupta, Sankalp Gupta, and Saksham Gupta serve as directors at the Company.
- CIN/LLPIN
U33125RJ1994PTC009129
- Company No.
009129
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dr. B. Lal Clinical Laboratory Private Limited offer?
Dr. B. Lal Clinical Laboratory Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiviral Drugs.
Who are the key members and board of directors at Dr. B. Lal Clinical Laboratory?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Banwari Gupta  | Managing Director | 08-Dec-1994 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sankalp Gupta | Director | 01-May-2012 | Current |
| Saksham Gupta | Director | 01-Aug-2012 | Current |
Financial Performance of Dr. B. Lal Clinical Laboratory.
Dr. B. Lal Clinical Laboratory Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 18.24% decrease. The company also saw a substantial fall in profitability, with a 41.07% decrease in profit. The company's net worth Soared by an impressive increase of 29.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. B. Lal Clinical Laboratory?
In 2021, Dr. B. Lal Clinical Laboratory had a promoter holding of 82.53% and a public holding of 17.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 27 Oct 2004 | ₹2.30 M | Satisfied |
How Many Employees Work at Dr. B. Lal Clinical Laboratory?
Dr. B. Lal Clinical Laboratory has a workforce of 347 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. B. Lal Clinical Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. B. Lal Clinical Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
